The role of polygenic risk scores in patients with idiopathic pulmonary fibrosis (IPF) may be influenced by telomere length, ...

Panelists discuss how incorporating advanced practice providers (APPs) into structured health-system pathways expands ...

Providing monthly produce prescriptions to patients with diabetes at risk for food insecurity did not significantly improve cardiometabolic parameters.

Jordan Karlitz, MD, highlights racial, ethnic, and socioeconomic disparities in rising CRC mortality rates among younger adults, driven by gaps in screening and awareness.

Panelists discuss how effective teamwork among advanced practice providers (APPs), neurologists, and primary care providers leads to better outcomes. They stress role clarity, mutual respect, and open ...

Sleep health is not equal among US adults, with new research implicating education level, age, body mass index (BMI), and ...

The FDA approved Optune Pax (Novocure), a first-in-class portable device that delivers tumor-treating fields (TTFields) to ...

PBM reforms, Medicare Advantage trends, TrumpRx launch, and Express Scripts settlement highlight key shifts in drug pricing, ...

An fresh look at trial results that propelled the only FDA approval of a chimeric antigen receptor (CAR) T-cell therapy for mantle cell lymphoma (MCL) shows prior treatment with ibrutinib, a ...

A new study links telomere length genetics to IPF risk, showing how rare variants and polygenic scores may guide future screening and precision care.

Vishal A. Patel, MD, explains that delayed skin cancer diagnoses contribute to more advanced disease and poorer outcomes in ...

This episode examines the barriers to accessing HER2-targeted therapies for non-small cell lung cancer (NSCLC) and strategies ...